Vaccine development and therapeutic design for 2019‐nCoV/SARS‐CoV‐2: Challenges and chances
Abstract The ongoing outbreak of the recently emerged 2019 novel coronavirus (nCoV), which has seriously threatened global health security, is caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) with high morbidity and mortality. Despite the burden of the disease worldwide, still,...
Saved in:
Main Authors: | Mahnaz Ghaebi, Abdolreza Osali, Hamed Valizadeh, Leila Roshangar, Majid Ahmadi |
---|---|
Format: | Revisão |
Language: | English |
Published: |
2020
|
Online Access: | https://doi.org/10.1002/jcp.29771 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vaccine development and therapeutic design for 2019‐nCoV/SARS‐CoV‐2: Challenges and chances
by: Ghaebi, Mahnaz, et al.
Published: (2020) -
Origins of MERS-CoV, and lessons for 2019-nCoV
by: Ji, John S
Published: (2020) -
Laboratory testing of SARS‐CoV, MERS‐CoV, and SARS‐CoV‐2 (2019‐nCoV): Current status, challenges, and countermeasures
by: Yan, Ying, et al.
Published: (2020) -
Laboratory testing of SARS‐CoV, MERS‐CoV, and SARS‐CoV‐2 (2019‐nCoV): Current status, challenges, and countermeasures
by: Ying Yan, et al.
Published: (2020) -
Comparison of Real‐Q 2019‐nCoV and DaAn Gene 2019‐nCoV polymerase chain reaction assays for the detection of SARS‐CoV‐2
by: Marembo, Takudzwa, et al.
Published: (2021)